Roivant insider plans sale of 243,177 shares

Roivant Sciences (ROIV) reporting person Mayukh Sukhatme filed a notice of proposed sale of 243,177 common shares, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

Roivant Sciences (ROIV) reporting person Mayukh Sukhatme filed a notice of proposed sale of 243,177 common shares, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares relate to an exercise of options under a registered plan, with a proposed sale date of August 14, 2026 on NASDAQ for cash.

The filing also lists prior sales during the past three months by Mayukh Sukhatme of 500,000 common shares on June 25, 2026 for $17,051,141.93 and 500,000 common shares on June 26, 2026 for $17,039,650.00.

Key Figures

Proposed shares to be sold: 243,177 shares Past sale 1: 500,000 shares Past sale 1 proceeds: $17,051,141.93 +3 more

6 metrics

Proposed shares to be sold 243,177 shares Common shares proposed for sale with planned date August 14, 2026

Past sale 1 500,000 shares Common shares sold on June 25, 2026 for $17,051,141.93

Past sale 1 proceeds $17,051,141.93 Proceeds from sale of 500,000 common shares on June 25, 2026

Past sale 2 500,000 shares Common shares sold on June 26, 2026 for $17,039,650.00

Past sale 2 proceeds $17,039,650.00 Proceeds from sale of 500,000 common shares on June 26, 2026

Proposed sale date August 14, 2026 Planned date for sale of 243,177 common shares on NASDAQ

Key Terms

Form 144, Exercise of Options Under a Registered Plan, Executive Financial Services

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Options Under a Registered Plan financial

"Exercise of Options Under a Registered Plan | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale is being proposed in the ROIV Form 144 filing?

The filing indicates a proposed sale of 243,177 common shares of Roivant Sciences, related to an exercise of options under a registered plan, with a proposed sale date of August 14, 2026 on NASDAQ for cash.

Who is the reporting person in the ROIV Form 144 and what is their broker?

The reporting person is Mayukh Sukhatme. The proposed sale of 243,177 common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction.

What prior ROIV share sales are disclosed in this Form 144?

The Form 144 lists two prior sales: 500,000 common shares on June 25, 2026 for $17,051,141.93, and another 500,000 common shares on June 26, 2026 for $17,039,650.00, both attributed to Mayukh Sukhatme.

How many ROIV shares in total are referenced in the recent sales section?

The recent sales section references 1,000,000 common shares sold in total, split into 500,000 shares sold on June 25, 2026 and 500,000 shares sold on June 26, 2026, with proceeds of over $34 million combined.

What is the nature of the planned ROIV share sale in the Form 144?

The planned sale of 243,177 common shares relates to an exercise of options under a registered plan, with the transaction designated as for cash and expected to occur on August 14, 2026 through NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 04:20 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001750050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD.
SEC File Number	001-40782
Address of Issuer	7th Floor 50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	44 207 400 3347
Name of Person for Whose Account the Securities are To Be Sold	MAYUKH SUKHATME
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	243177	8809767.72	722323000	08/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2026	Exercise of Options Under a Registered Plan	Issuer			243177	08/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MAYUKH SUKHATME 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/26/2026	500000	17039650.00
Mayukh Sukhatme 7th Floor 50 Broadway London X0 SW1H 0DB	Common	06/25/2026	500000	17051141.93

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mayukh Sukhatme
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)